Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Morehouse School of Medicine manages a company patent portfolio within the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 4 pending office actions, which indicates a level of active prosecution. These actions are distributed across 3 distinct examiners and 3 distinct art units. This distribution suggests that the school's research and development efforts are spread across several specialized niches within the broader biotechnology sector rather than being confined to a single path.
The busiest examiner for this portfolio is AUDET, MAURY A, who is currently handling 2 busiest examiner pending actions. This means that some of the 4 pending office actions for the company are concentrated under this one individual. The remaining actions are split among the other distinct examiners. For a practitioner, this concentration highlights AUDET, MAURY A as a critical figure in the current prosecution cycle. The involvement of the 3 distinct art units further confirms that the portfolio requires navigation through multiple specialized examination groups at the patent office. Each of the distinct examiners plays a role in resolving the pending office actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AUDET, MAURY A | 2 | 50.1% | +23.9% |
| BARSKY, JARED | 1 | 50.2% | +22.7% |
| SITTON, JEHANNE SOUAYA | 1 | 53.2% | +48.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17305480 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18527676 | COMPOSITION FOR TREATING ACUTE BRAIN INJURY OR NEURODEGENERATIVE DISEASE, METHOD OF MAKING, AND USE THEREOF | BARSKY, JARED | 29d overdue |
| 18536722 | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES | AUDET, MAURY A | — |
| 17662783 | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES | AUDET, MAURY A | — |
| 17305480 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1628 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18536722 | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES | AUDET, MAURY A | 1654 | §103DP | Final Rejection | — | Pending | Dec 12, 2023 |
| 18527676 | COMPOSITION FOR TREATING ACUTE BRAIN INJURY OR NEURODEGENERATIVE DISEASE, METHOD OF MAKING, AND USE THEREOF | BARSKY, JARED | 1628 | §103 | Final Rejection | 29d overdue | Pending | Dec 04, 2023 |
| 17662783 | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES | AUDET, MAURY A | 1654 | §112 | Non-Final OA | — | Pending | May 10, 2022 |
| 17305480 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | 1682 | §103§112 | Final Rejection | — | Pending | Jul 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial